HM PAYSON & CO - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 360 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
HM PAYSON & CO ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,056
-22.4%
650.0%0.00%
Q2 2023$2,651
+9.4%
650.0%0.00%
Q1 2023$2,423
+6.8%
650.0%0.00%
Q4 2022$2,268
-43.3%
650.0%0.00%
Q3 2022$4,000
+33.3%
650.0%0.00%
Q2 2022$3,000
-40.0%
650.0%0.00%
Q1 2022$5,000
-37.5%
650.0%0.00%
Q4 2021$8,000
-11.1%
650.0%0.00%
Q3 2021$9,000650.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,615,321$23,697,00041.29%
ARK Investment Management 8,741,432$128,237,0003.23%
Nikko Asset Management Americas, Inc. 7,178,520$105,309,0001.66%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$1,635,0000.86%
Elmwood Wealth Management, Inc. 64,204$942,0000.82%
361 CAPITAL LLC 94,772$1,390,0000.38%
Artal Group S.A. 199,700$2,930,0000.11%
StoneX Group Inc. 14,982$220,0000.09%
Sumitomo Mitsui Trust Holdings, Inc. 7,178,520$105,309,0000.08%
PDT Partners, LLC 85,517$1,255,0000.08%
View complete list of INTELLIA THERAPEUTICS INC shareholders